Combination Chemotherapy of Lung Cancer – Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid–Polymer Hybrid Nanoparticles

Selective Detection of Human Lung Adenocarcinoma Cells Based on the Aptamer-Conjugated Self-Assembled Monolayer of Gold Nanoparticles

(2019) Ngoc-Viet Nguyen et al.   Micromachines

A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells

(2019) Yinxing Shen et al.   International Journal of Nanomedicine

Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates

(2019) Koita Sacko et al.   Nanomaterials

HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation

(2019) Tao Duan et al.   BIOMEDICINE & PHARMACOTHERAPY

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy

(2019) Xueyan Zhang et al.   Dose-Response

Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin

(2019) Yan Nan   ONCOLOGY REPORTS

Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo

(2019) Shira Engelberg et al.   Cell Death & Disease

Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin

(2019) Shenghu Guo et al.   BIOMEDICINE & PHARMACOTHERAPY

EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer

(2019) Yuyu Zhao et al.   MOLECULAR PHARMACEUTICS

Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: In vitro and in vivo evaluation

(2019) Jinli Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy

(2018) Guowen Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment

(2018) Yu Song et al.   International Journal of Nanomedicine

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells

(2018) Daniela Catanzaro et al.   Oncotarget

Cancer cell-selective, clathrin-mediated endocytosis of aptamerdecorated nanoparticles

(2018) Shira Engelberg et al.   Oncotarget

The Length of Hydrophobic Chain in Amphiphilic Polypeptides Regulates the Efficiency of Gene Delivery

(2018) Ying Zhang et al.   Polymers

Aptamer Therapeutics in Cancer: Current and Future

(2018) Yoshihiro Morita et al.   Cancers

Targeting lung cancer initiating cells by all‑trans retinoic acid‑loaded lipid‑PLGA nanoparticles with CD133 aptamers

(2018) Yu Zhang et al.   Experimental and Therapeutic Medicine

Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly(ethylene glycol)-ε-poly(caprolactone) nanocarriers

(2018) Zhiyu Wang et al.   Drug Design Development and Therapy

Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles

(2018) Jia Liu et al.   Drug Design Development and Therapy

Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers

(2018) Meng Li et al.   Acta Pharmaceutica Sinica B

Hypoxia-activated prodrugs and redox-responsive nanocarriers

(2018) Yun Zeng et al.   International Journal of Nanomedicine

Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer

(2018) Fenfen Gu et al.   JOURNAL OF NANOPARTICLE RESEARCH

AS1411 aptamer-decorated cisplatin-loaded poly(lactic-co-glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells

(2018) Somayeh Vandghanooni et al.   Nanomedicine

Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity

(2018) Feng Yang et al.   Drug Design Development and Therapy

EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer

(2017) Yang Li et al.   International Journal of Nanomedicine

Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens

(2017) Lan Wu et al.   JOURNAL OF CONTROLLED RELEASE

Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment

(2016) DongMei Yu et al.   BIOMEDICINE & PHARMACOTHERAPY

Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy

(2016) Zhihe Lu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma

(2016) Can Wang et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Development and in vitro evaluation of core–shell type lipid–polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer

(2016) Bivash Mandal et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins

(2016) Sunday Shoyele et al.   International Journal of Nanomedicine

Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer

(2016) Yang Xiong et al.   JOURNAL OF CONTROLLED RELEASE

Polymer–lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin–mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor

(2016) Rui Xue Zhang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment

(2015) Liqiong Cai et al.   BIOMATERIALS

Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy

(2015) Guilian Zhang et al.   DRUG DELIVERY

Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid–polymer hybrid nanoparticles for the enhanced anti-tumor activityin vitroandin vivo

(2015) Jieke Yan et al.   DRUG DELIVERY

Mechanistic profiling of the siRNA delivery dynamics of lipid–polymer hybrid nanoparticles

(2015) Stefano Colombo et al.   JOURNAL OF CONTROLLED RELEASE

Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells

(2015) Hongmei Wang et al.   PLoS One

Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines – Lessons for design of combination targeted therapy

(2012) Brian J. Park et al.   CANCER LETTERS

Submersible microbial fuel cell sensor for monitoring microbial activity and BOD in groundwater: Focusing on impact of anodic biofilm on sensor applicability

(2011) Yifeng Zhang et al.   BIOTECHNOLOGY AND BIOENGINEERING

Antibody engineering promotes nanomedicine for cancer treatment

(2010) Jie Gao et al.   Nanomedicine